Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01455402 · ClinicalTrials.gov registry record
An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 476
- Enrollment target
NCT01455402 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 476 participants.
The verdict
NCT01455402 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 476 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to worsening cardiorespiratory status (ie, acute exacerbations of chronic obstructive pulmonary disease \[AECOPD\] or worsening CHF) associated with RSV infections in high-risk adults (ie, those with severe COPD and/or advanced CHF) across multiple consecutive RSV seasons.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 476 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01455402
The ClinicalTrials.gov registry entry for NCT01455402 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 476 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01455402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01455402 about?
NCT01455402 is a clinical study titled "An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF". The primary objective of this observational study is to determine the incidence of medically attended (inpatient or outpatient) acute respiratory illnesses or events leading to worsening cardiorespiratory status (ie, acute exacerbations of chronic obstructive pulmonary disease \[AECOPD\] or worsenin...
What is the current status of trial NCT01455402?
This trial is currently completed. The enrollment target is 476 participants. The study started on 2010-07. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01455402?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.